Precision Oncology
Reveal Genomics' HER2DX Assay De-Escalates Early Breast Cancer Treatment in Real-World Study
Premium
The observational study measured how physicians changed treatment plans after seeing HER2DX results and how patients did on the new plans.
Anixa Biosciences Nabs Option to Develop Cancer Vaccines With Verdi Solutions
If Anixa exercises its rights, Verdi and Anixa will collaborate on trials in the US, while Verdi will continue developing personalized vaccines in Europe.
Ontario Brain Institute, EpiSign Partner on Rare Genetic Disorder Diagnosis
OBI's Center for Analytics and EpiSign will refine and validate EpiSign's machine-learning algorithm that analyzes a person's epigenome to detect rare genetic disorders.
Verve Therapeutics to Kick off Base-Editing Cardiovascular Drug Phase I Trial in the US
The firm's Heart-2 study of VERVE-102, which is designed to inactivate the PCSK9 gene, is already underway in Canada and the UK.
FDA Approves Telix Radiopharmaceutical Imaging Agent Gozellix to ID PSMA-Positive Prostate Cancer
The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.
Mar 13, 2025